| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals, Inc. (SNDX) has 3 insiders with recent SEC Form 4 filings, including 4 buys and 11 sells. SNDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.8K | $9.37M | -6,847 | |
| CFO | 139.3K | $2.69M | -1,177 | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | Egros Fabrice | Director | Sale+OE | 10,241 | $24.31 | $248,981.24 | -24.2% | |
| Feb 8, 2021 | Morrison Briggs61 | Chief Executive Officer | Sale+OE | 35,156 | $20.55 | $722,403.07 | -42.1% | |
| Feb 1, 2021 | Metzger Michael A52 | President And COO | Sale+OE | 15,000 | $20.19 | $302,799.00 | -45.9% | |
| Dec 1, 2020 | Metzger Michael A52 | President And COO | Sale+OE | 15,000 | $22.97 | $344,512.50 | -45.9% | |
| Nov 23, 2020 | Ordentlich Peter66 | Chief Scientific Officer | Sale+OE | 29,972 | $23.16 | $694,121.36 | -42.5% | |
| Nov 10, 2020 | Morrison Briggs61 | Chief Executive Officer | Sale+OE | 80,404 | $20.04 | $1,611,577.00 | -46.3% | |
| Nov 4, 2020 | Metzger Michael A52 | President And COO | Sale+OE | 100,000 | $20.31 | $2,031,410.00 | -85.0% | |
| Feb 4, 2020 | Morrison Briggs61 | Chief Executive Officer | Buy | 12,500 | $8.00 | $100,000.00 | +39.8% | |
| Oct 10, 2019 | Morrison Briggs61 | Chief Executive Officer | Buy | 11,000 | $5.40 | $59,400.00 | +53.9% | |
| May 13, 2019 | Morrison Briggs61 | Chief Executive Officer | Buy | 20,400 | $7.46 | $152,242.80 | +154.5% |